(Q79316104)
Statements
Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers (English)
Vaidyanathan S
Valencia J
Kemp C
Zhao C
Yeh CM
Bizot MN
Denouel J
Dieterich HA
1 November 2006